A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentations have concluded.

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

Rapport Therapeutics (RAPP) announced two encore poster presentations at the 2025 American Academy of Neurology, AAN, Annual Meeting, taking ...

today announced two abstracts accepted for poster presentations at the upcoming European Lung Cancer Congress (ELCC) 2025 Scientific Committee and Mayo Clinic Multidisciplinary Head and Neck ...

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through its contractual relationship with BioDuro-Sundia, a provider of ...

Annual Meeting, taking place April 5-9, 2025, in San Diego, California. Ulviprubart is a first-in-class monoclonal antibody targeting killer cell lectin like receptor G1 (KLRG1), currently being ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Everyone is welcome here, or not everyone is welcome here,” argues Sarah Inama, a sixth-grade history teacher.

today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting taking place March 12-14 ...

House Oversight and Reform Committee Chairman James Comer launched an investigation into the policies of sanctuary cities for ...